Author name: muutaa

Dirty data can easily derail any big data analytics project, especially when bringing together several healthcare data sources that may record clinical or operational elements in slightly different formats.  Several data conventions in healthcare hinder the widespread use of data analytics. Currently, health care data are split among different entities and have different formats such […]

Pioneering the functional application of artificial intelligence in the healthcare enterprise, MUUTAA seeks out the areas where sufficient data is at the disposition of our partners to deploy intelligence and reduce time spent on repetitive tasks or tasks with a high cognitive burden. The ultimate goal being to elevate care givers to perform higher value

There is tremendous complexity involved in developing AI and machine learning solutions that meet a business’ actual needs. Developing the right algorithms requires data scientists who know what they are looking for and why, to cull useful information and predictions that deliver on the promise of AI. However, it is not feasible or cost-effective for

As part of his article on forbes.com ‘The 4 top artificial intelligence trends for 2021’, Bernard Marr talks about the innovation potential (and need), specifically coming apparent during the COVID-19 pandemic. He mentions that ‘The COVID-19 pandemic has impacted many aspects of how we do business, but it hasn’t diminished the impact artificial intelligence is

As an organization that drives the democratization of artificial intelligence in the Canadian private and public healthcare sector we understand the Canadian AI paradox. We are and aspire to remain a global leader in AI developments and breakthroughs, however adoption of AI in our businesses and in the public domain evolves slower than expected.  

Towards the end of April this year, we launched the COVID-19 Urban Resurgence Simulator. Looking at the current epidemiologic developments as we get into the fall season, the pertenance of modeling the SARS-CoV2 developments become even more clear. Continuous efforts in defining and refining parametres in the simulator are ongoing. This all in an effort

SARS-CoV2 vaccine supply chain complexities start to dominate the discussion around the capacity of the existing infrastructure to be capable of mass vaccination in a timely and efficient manner.   Katharin Czink and Dina Bair describe the current state and characteristics of the vaccines under development. Most of the experimental vaccines require two doses given

Can re-opening of our economies occur safely without significantly impacting PPE availability for critical care? The global PPE supply chains are continuing to struggle to keep up with demand. Globally more and more countries are mandating the use of PPE in public life and availability of raw materials for the production of PPE is under

In his article “Artificial Intelligence in Healthcare: A Post-Pandemic Prescription” David Nash, describes the several challenges that need to be overcome for AI to be a game changer. He refers to Robert Pearl, MD, a well-known advocate for technologically advanced care delivery, who recently stated; “If AI is to live up to its hype in